StockData
Damora Therapeutics, Inc. logo

Damora Therapeutics, Inc. (DMRA) KPIs and segments

DMRANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 6/30
$22.56+0.06 (+0.29%)

Close on Nov 17, 2026Market cap $1.39BP/E 5.7Yield 0.00%

KPIs & segments

Operating metrics and segments that drive Damora Therapeutics's business

Coming soon

This tab will track the numbers specific to Damora Therapeutics's business model — such as store count, revenue by banner, revenue per store and new openings — taken from filings and earnings releases.

See a number that looks wrong?